Roadside screening tests for cannabis use: A systematic review
- PMID: 37064483
- PMCID: PMC10102219
- DOI: 10.1016/j.heliyon.2023.e14630
Roadside screening tests for cannabis use: A systematic review
Abstract
As more countries legalize recreational cannabis, roadside screening programs are imperative to detect and deter driving under the influence of cannabis. This systematic review evaluated roadside screening tests for cannabis use. We searched six databases (inception-March 2020) and grey literature sources for primary studies evaluating test characteristics of roadside screening tests for cannabis use compared to laboratory tests for cannabinoids in blood or oral fluid. The synthesis was focused on sensitivity and specificity of delta-9-tetrahydrocannabinol (THC) detection. 101 studies were included. Oral fluid tests were higher in specificity and lower in sensitivity compared to urine tests when evaluated against blood laboratory tests. Oral fluid tests were higher in sensitivity and similar in specificity compared to observational tests when evaluated against blood and oral fluid laboratory tests. Sensitivity was variable among oral fluid tests; two instrumented immunoassays (Draeger DrugTest 5000 [5 ng/mL THC cut-off] and Alere DDS 2 Mobile Test System) appeared to perform best, but definitive conclusions could not be drawn due to imprecise estimates. Specificities were similar. Overall, oral fluid tests showed the most promise for use in roadside screening for blood THC levels over legal limits; their continued development and testing are warranted. Urine tests are generally inadvisable, and observational tests require sensitivity improvements.
Keywords: Cannabis; DUIC; Impaired driving; Systematic review.
©2023PublishedbyElsevierLtd.
Figures
Similar articles
-
Reliability of roadside oral fluid testing devices for ∆9-tetrahydrocannabinol (∆9-THC) detection.Drug Test Anal. 2024 Dec;16(12):1528-1536. doi: 10.1002/dta.3669. Epub 2024 Mar 5. Drug Test Anal. 2024. PMID: 38440942
-
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration.Clin Chem. 2017 Mar;63(3):647-662. doi: 10.1373/clinchem.2016.265371. Epub 2017 Feb 10. Clin Chem. 2017. PMID: 28188235 Clinical Trial.
-
Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.Accid Anal Prev. 2022 Aug;173:106694. doi: 10.1016/j.aap.2022.106694. Epub 2022 May 26. Accid Anal Prev. 2022. PMID: 35640367
-
Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.Forensic Sci Int. 2006 Sep 12;161(2-3):175-9. doi: 10.1016/j.forsciint.2006.03.033. Epub 2006 Jul 13. Forensic Sci Int. 2006. PMID: 16842950
-
Are oral fluid testing devices effective for the roadside detection of recent cannabis use? A systematic review.Public Health. 2019 Jun;171:57-65. doi: 10.1016/j.puhe.2019.03.006. Epub 2019 May 15. Public Health. 2019. PMID: 31102828
Cited by
-
Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS.Anal Bioanal Chem. 2025 Jan;417(2):345-360. doi: 10.1007/s00216-024-05651-9. Epub 2024 Dec 3. Anal Bioanal Chem. 2025. PMID: 39625516
-
Metabolomic profiling of cannabis use and cannabis intoxication in humans.Neuropsychopharmacology. 2025 May;50(6):920-927. doi: 10.1038/s41386-025-02082-7. Epub 2025 Mar 12. Neuropsychopharmacology. 2025. PMID: 40074870 Free PMC article.
-
Recent advances in the development of portable technologies and commercial products to detect Δ9-tetrahydrocannabinol in biofluids: a systematic review.J Cannabis Res. 2024 Feb 27;6(1):9. doi: 10.1186/s42238-024-00216-0. J Cannabis Res. 2024. PMID: 38414071 Free PMC article. Review.
-
Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.Front Public Health. 2023 Nov 22;11:1234765. doi: 10.3389/fpubh.2023.1234765. eCollection 2023. Front Public Health. 2023. PMID: 38074719 Free PMC article. Clinical Trial.
-
Detection of Δ9-tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol containing oil.Drug Test Anal. 2024 Dec;16(12):1487-1495. doi: 10.1002/dta.3658. Epub 2024 Feb 27. Drug Test Anal. 2024. PMID: 38414100 Free PMC article. Clinical Trial.
References
-
- Rogeberg O., Elvik R. The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction. 2016;111(8):1348–1359. - PubMed
-
- AH E. Marijuana use and driving in Washington State: risk perceptions and behaviors before and after implementation of retail sales. Traffic Inj. Prev. 2019;20(1):23–29. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials